Business Context and Reporting Period
Company: GSK plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of July 2025
Announcement Date: July 18, 2025
Subject: Transaction in own shares (Share Buyback)
Key Financial Metrics and Transaction Details
This filing details a specific share repurchase transaction executed on July 17, 2025, under an existing buyback programme. The filing does not contain revenue, profit, or cash flow data for the period.
| Metric | Value |
|---|---|
| Shares Purchased (July 17, 2025) | 484,633 |
| Lowest Price Paid | 1,403.50 GBp |
| Highest Price Paid | 1,422.00 GBp |
| Volume-Weighted Average Price | 1,413.20 GBp |
| Trading Venue | London Stock Exchange (XLON) |
| Broker | Merrill Lynch International |
Material Changes and Programme Status
- Cumulative Purchases: Since the commencement of the current non-discretionary agreement on June 4, 2025, the Company has purchased a total of 14,177,313 ordinary shares.
- Treasury Shares: Following this transaction, GSK holds 232,311,696 ordinary shares in treasury.
- Shares in Issue: The total number of ordinary shares in issue (excluding treasury shares) is 4,083,072,361.
- Voting Rights: Treasury shares represent 5.69% of the total voting rights in the Company.
Guidance, Outlook, and Risks
The filing contains no new financial guidance or operational outlook. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the Company's 2024 Annual Report on Form 20-F and Q1 2025 Results.
Key Facts for Investor Verification
- Verify the total remaining authorization under the share buyback programme announced on June 4, 2025.
- Confirm the impact of the 5.69% treasury share holding on earnings per share (EPS) calculations.
- Review the "Risk Factors" section of the 2024 Form 20-F for context on the forward-looking statement disclaimer.
- Note that all transactions were executed on the London Stock Exchange; no trades occurred on CBOE Europe venues (CHIX or BATE) on this date.